School of Medicine
Showing 191-200 of 609 Results
-
Benjamin Daniel Greenberg
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Greenberg provides direct psychological care to patients in the ADAPT (Adult Depression and Anxiety Psychological Treatment) & Dual Diagnosis clinics. He is passionate about delivering evidence-based psychotherapies that are responsive and personal. He conducts individual as well as group therapy.
He teaches a psychotherapy didactic to the Addiction Medicine fellows as well as provides clinical supervision to post-doctoral fellows, doctoral students, and psychiatry residents. He is committed to helping trainees learn & work through complex situations that arise in individual & group psychotherapy. -
J. Christian Greer
Lecturer, Psychiatry and Behavioral Sciences
BioJ. Christian Greer, PhD, is a scholar of Religious Studies with a special focus on psychedelic culture. He holds a MDiv from Harvard Divinity School, as well as a MA and PhD (cum laude) in Western Esotericism from the University of Amsterdam. While a postdoctoral researcher at Harvard Divinity School, he led a series of seminars on global psychedelic cultures, which culminated in the creation of the "Harvard Psychedelic Walking Tour," a free audio guide detailing how the Harvard community has shaped the modern history of psychedelic culture. He is also the co-founder, and currently the co-chair of the "Drugs and Religion" program unit at the American Academy of Religion.
His forthcoming book, "Angelheaded Hipsters: Psychedelic Militancy in Nineteen Eighties North America" (Oxford University Press), explores the expansion of psychedelic culture within fanzine networks in the late Cold War era. He has held teaching positions at Harvard University and Yale University, and is currently a lecturer at Stanford University. His other books include, "Void Machines: the Paper Shrines of J. Christian Greer," a collection of his esoteric artworks, and "Kumano Kodo: Pilgrimage to Powerspots" (co-authored with Dr. Michelle Oing) which analyzes the pilgrimage folklore associated with the rainforests of Japan's Kii Peninsula.
Each winter, he partners with the University of Amsterdam to offer an introduction to the study of occultism, hosted on ZOOM, entitled "FORBIDDEN KNOWLEDGE: Introduction to Esotericism." Similarly, each summer, he organizes an intensive summer school course on the University of Amsterdam's campus entitled, "THE PSYCHEDELIC UNIVERSE: Global Perspectives on Higher Consciousness." -
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Founding Director of the Stanford Center for Memory Disorders and Principal Investigator of a lab focused on the genetics of Alzheimer's disease (AD), Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Ilang M. Guiroy, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Ilang M. Guiroy is a board-certified, fellowship-trained psychiatrist at Stanford Health Care and Lucile Packard Children’s Hospital Stanford. She is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Guiroy treats mental health conditions in patients throughout the lifespan, from childhood to old age. She also specializes in infant, child, and maternal mental health and provides medication management during pregnancy, postpartum, and chestfeeding. Dr. Guiroy provides expert support to patients coping with birth trauma, transitioning to motherhood, and fostering infant attachment and maternal bonding. Dr. Guiroy is skilled in maternal-infant therapy, interpersonal therapy, and cognitive behavioral therapy (CBT).
Dr. Guiroy is director of the Guiroy Lab at Stanford Maternal and Child Health Research Institute. Her research explores maternal-infant mental health and digital mental health, including the use of social media, digital communities, and AI for mental health. She developed a groundbreaking telehealth platform to deliver psychotherapy via group chat to digital communities.
Dr. Guiroy has published her research in peer-reviewed journals, including Journal of Technology in Behavioral Science and Telemedicine and e-Health. She has also presented to her peers at national conferences for the American Academy of Child and Adolescent Psychiatry (AACAP) and the Society for Digital Mental Health (SDMH).
Dr. Guiroy is a member of the AACAP, the SDMH, the American Psychiatric Association (APA), and the International Marcé Society for Perinatal Mental Health. -
Matthew Gunther, MD, MA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on neuropsychiatric syndromes arising in the context of medical illness, with particular emphasis on delirium, catatonia, psychopharmacology in the medically ill, and the psychiatric sequelae of critical illness. His research spans the identification, assessment, and management of acute brain dysfunction in hospitalized and critically ill populations, including studies evaluating delirium prediction tools, bedside diagnostic instruments, and neurorecovery outcomes following medical insults. He has contributed to the validation and clinical application of the Stanford Proxy Test for Delirium (S-PTD) and related delirium risk stratification efforts, and has authored systematic reviews and case-based scholarship addressing catatonia, alcohol withdrawal syndromes, and medication-related neurotoxicity. In parallel, Dr. Gunther’s work in integrated behavioral health and medical education examines how psychiatry-led, skills-based interventions can improve recognition of neuropsychiatric and trauma-related symptoms in primary care and inpatient medical settings. Across these domains, his research emphasizes translational, clinically grounded approaches that equip non-psychiatric clinicians to manage complex neuropsychiatric presentations with greater confidence and precision.
-
Laura Michele Hack
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Laura M. Hack is an Assistant of Psychiatry and Behavioral Sciences at Stanford University and the Veterans Affairs Palo Alto Health Care System (PAVAHCS). As Associate Director of the Novel & Precision Neurotherapeutics Program at the Stanford Center for Precision Mental Health, Dr. Hack leads a translational, patient-centered research group that designs and implements mechanistic clinical trials for biologically informed subtypes of Mood, Anxiety, and Trauma-related Disorders (MATRDs).
Her work spans repurposed pharmacologic interventions (e.g., guanfacine), neuromodulation techniques (e.g., repetitive transcranial magnetic stimulation [TMS]), and therapies involving altered states of consciousness (i.e., ketamine, MDMA, psilocybin, and anesthesia-induced dreaming). Across these modalities, Dr. Hack's focus is on tailoring treatment based on objective, biologically anchored markers that match the patient’s profile.
Dr. Hack also directs the Stanford Precision Psychiatry Clinic, a high-touch, high-tech consultation service designed to support individuals with a primary diagnosis of major depression and often comorbid MATRDs. This clinic integrates the investigational use of high-definition neuroimaging (personalized brain circuit scores) with symptom profiling, neurocognitive testing, pharmacogenomic analysis, inflammatory biomarkers, and standard blood work. The aim is to generate individualized insights that inform treatment decisions and help patients better understand the biological underpinnings of their condition—often reducing self-blame and empowering engagement in care.
In her role as Deputy Director as well as Ketamine and Education Lead of the Precision Neuromodulation Clinic (PNC) at PAVAHCS, Dr. Hack specializes in delivering evidence-based, FDA-cleared interventions including TMS and intranasal ketamine for Veterans experiencing treatment-resistant depression, frequently in the context of comorbid PTSD. -
Scott S. Hall, Ph.D
Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
